These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 516573)

  • 1. [Bioenergetic metabolism in ovarian cancer treated with cyclophosphane in combination with hyperbaric oxygenation].
    Zel'vin BM; Vedernikova NV
    Vopr Onkol; 1979; 25(11):85-6. PubMed ID: 516573
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of antitumor preparations under hyperbaric oxygenation in ovarian cancer].
    Dar'ialova SL; Vedernikova NV; Bergut FL; Zel'vin BM
    Akush Ginekol (Mosk); 1979 Dec; (12):34-6. PubMed ID: 532873
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nonspecific immunity indices in ovarian cancer during cyclophosphane treatment under a varying oxygen regimen].
    Sokolova II; Kochetkova VA; Repina FB; Vedernikova NV
    Akush Ginekol (Mosk); 1980 Jun; (6):20-2. PubMed ID: 7406165
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of hyperoxia on brain energy metabolism with the combined action of monoiodoacetate].
    Rubel' LN; Ivanova TN
    Vopr Med Khim; 1973; 19(1):78-84. PubMed ID: 4788009
    [No Abstract]   [Full Text] [Related]  

  • 5. Advanced ovarian cancer: therapy with radiation and cyclophosphamide in a random series.
    Johnson CE; Decker DG; Van Herik M; Mussey E; Malkasian GD; Jorgensen EO
    Am J Roentgenol Radium Ther Nucl Med; 1972 Jan; 114(1):136-41. PubMed ID: 4550548
    [No Abstract]   [Full Text] [Related]  

  • 6. [Report on the management of advanced ovarian cancer using Endoxan (Asta) and cyclophosphamide preparations].
    Dvorák O; Spirová M
    Zentralbl Gynakol; 1967 Jul; 89(26):940-5. PubMed ID: 5587033
    [No Abstract]   [Full Text] [Related]  

  • 7. 5-FU infusion and cyclophosphamide in the treatment of advanced ovarian cancer.
    Izbicki RM; Baker LH; Samson MK; McDonald B; Vaitkevicius VK
    Cancer Treat Rep; 1977 Nov; 61(8):1573-5. PubMed ID: 922760
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy of patients with recurring malignant tumors of the ovaries].
    Kotova DG; Vinokurov VL
    Vopr Onkol; 1975; 21(4):19-23. PubMed ID: 812259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian carcinoma treated with cyclophosphamide (Endoxan).
    Hsii FP; Jayaratnam FJ; Siang SC
    Singapore Med J; 1968 Sep; 9(3):195-7. PubMed ID: 5710986
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic trial of a combination of cytostatic agents in advanced ovarian carcinoma].
    Brandl K
    Zentralbl Gynakol; 1970 Feb; 92(8):233-9. PubMed ID: 5505972
    [No Abstract]   [Full Text] [Related]  

  • 11. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
    Barlow JJ; Piver MS
    Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with clinical use of cyclophosphane].
    Raevskiĭ IG
    Klin Med (Mosk); 1966 Jan; 44(1):98-103. PubMed ID: 4293574
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of platinum plus cyclophosphamide in patients with epithelial ovarian cancer.
    Tangjitgamol S; Mamusirinitaya S; Leelahakorn S; Thawaramara T; Pataradool K; Suekwatana P; Sittidilokratna K
    J Med Assoc Thai; 2005 Sep; 88(9):1172-81. PubMed ID: 16536101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of 96-hr continuous-infusion etoposide and doxorubicin with bolus cyclophosphamide in refractory epithelial ovarian cancer.
    Fleming GF; Waggoner SE; Rotmensch J; Skoog LA; Langhauser C
    Gynecol Oncol; 1997 Apr; 65(1):42-5. PubMed ID: 9103389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of patients with malignant ovarian tumors with high single doses of cyclophosphane].
    Loskutova GP
    Vopr Onkol; 1973; 19(9):98-9. PubMed ID: 4788400
    [No Abstract]   [Full Text] [Related]  

  • 16. [Controlled prospective study of chemotherapy in advanced ovarian cancer--cyclophosphamide monochemotherapy versus polychemotherapy with adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate].
    Chylak V; Kolarić K; Krusić J
    Lijec Vjesn; 1987 Jun; 109(6):230-4. PubMed ID: 3309515
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chemotherapy of malignant ovarian tumors].
    Pickel H; Lahousen M
    Wien Med Wochenschr; 1977 Sep; 127(17):539-41. PubMed ID: 919568
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma.
    Decker DG; Fleming TR; Malkasian GD; Webb MJ; Jeffries JA; Edmonson JH
    Obstet Gynecol; 1982 Oct; 60(4):481-7. PubMed ID: 6889714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclophosphamide as adjuvant treatment of the advanced ovarian carcinoma].
    Malkasian GD; Mussey E; Decker DG; Johnson CE
    Gynecol Prat; 1967; 18(6):545-53. PubMed ID: 4316435
    [No Abstract]   [Full Text] [Related]  

  • 20. [Endolymphatic polychemotherapy of cancer of the ovaries].
    Pankov AK; Sidorenko IuS; Il'inskaia EG; Birbraer VM
    Vopr Onkol; 1975; 21(4):55-7. PubMed ID: 812260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.